Drugs / TreeMATA
last change Jul 2007 re-read 3 minutes ago

TreeMATA

Vaccine

Developed for
hypersensitivity reaction disease
Investigated by
Allergy Therapeutics

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00387478 Oct 2006 → Jul 2007 hypersensitivity reaction disease Allergy Therapeutics Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TreeMATA “TreeMATAMPL (Allergy Therapeutics, (UK) Ltd.), TreeMATA (Allergy Therapeutics, (UK) Ltd.)” NCT00387478 ↗
1

NCT00387478 ↗

Modality Vaccine “designed to provide a vaccine” NCT00387478 ↗